HDFC Pharma and Healthcare Fund

HDFC Mutual FundThematicPortfolio as of 31 August 2026

HDFC Pharma and Healthcare Fund holds 41 instruments (98.42% equity), led by Divi's Laboratories Limited (9.54%), Sun Pharmaceutical Industries Limited (8.94%) and Torrent Pharmaceuticals Limited (4.08%), as of its 31 August 2026 SEBI-mandated monthly disclosure.

Holdings
41
Equity Allocation
98.42%
AMC
HDFC Mutual Fund
Category
Thematic

This page shows the complete disclosed portfolio of HDFC Pharma and Healthcare Fund, managed by HDFC Mutual Fund, based on its monthly portfolio disclosure dated 31 August 2026. The fund holds 41 instruments with an equity allocation of 98.42%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.

Portfolio Analysis

HDFC Pharma and Healthcare Fund's top 10 holdings account for 48.86% of its portfolio, in line with the Thematic category average of 49.2%. Healthcare is its largest sector exposure at 98.42% of net assets, spread across 1 sector in total. Since its 31 July 2026 disclosure, the fund added 2 new positions and exited 0 positions, with Torrent Pharmaceuticals Limited seeing the largest move (+1.8pp to 4.08%).

Sector Breakdown

Equity holdings grouped by sector, % to NAV. "Other" covers debt, cash and other non-equity instruments, plus any equity holding without a classified sector.

Healthcare
98.42%
Other
1.58%

Top 10 Equity Holdings

What Changed: July 2026 → August 2026

Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.

2 new entries5 increased10 reduced

Biggest Weight Increases

StockWeightChange
Torrent Pharmaceuticals Limited2.28% → 4.08%▲ +1.8
Rubicon Research Limited1.61% → 2.82%▲ +1.21
Shilpa Medicare Limited2.25% → 3.1%▲ +0.85
Divi's Laboratories Limited9.14% → 9.54%▲ +0.4
Neuland Laboratories Limited3.4% → 3.7%▲ +0.3

Biggest Weight Reductions

StockWeightChange
Aster DM Healthcare Limited4.7% → 3.84%▼ -0.86
Max Healthcare Institute Limited4.82% → 4.06%▼ -0.76
Sun Pharmaceutical Industries Limited9.66% → 8.94%▼ -0.72
Cipla Limited4.64% → 3.94%▼ -0.7
Lupin Limited4.67% → 4.04%▼ -0.63
Alkem Laboratories Limited3.67% → 3.06%▼ -0.61
JUPITER LIFE LINE HOSPITALS2.45% → 1.94%▼ -0.51
Krishna Institute of Medical Sciences Limited2.7% → 2.25%▼ -0.45
Fortis Healthcare Limited2.79% → 2.37%▼ -0.42
Acutaas Chemicals Limited3.58% → 3.24%▼ -0.34

Top Holdings — Weight Trend

% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Mar – Aug 2026).

Mar: 8.2%, Apr: 8.56%, May: 8.02%, Jun: 7.16%, Jul: 9.14%, Aug: 9.54%
9.54%
Mar: 10.2%, Apr: 8.05%, May: 9.2%, Jun: 9.96%, Jul: 9.66%, Aug: 8.94%
8.94%
Mar: 2.34%, Apr: 2.13%, May: –, Jun: –, Jul: 2.28%, Aug: 4.08%
4.08%
Mar: 5.96%, Apr: 5.93%, May: 5.26%, Jun: 5.57%, Jul: 4.82%, Aug: 4.06%
4.06%
Mar: 6.65%, Apr: 6.07%, May: 5.45%, Jun: 5.26%, Jul: 4.67%, Aug: 4.04%
4.04%

Full Portfolio (41 holdings)

#HoldingSector% to NAV
1Divi's Laboratories LimitedHealthcare9.54%
2Sun Pharmaceutical Industries LimitedHealthcare8.94%
3Torrent Pharmaceuticals LimitedHealthcare4.08%
4Max Healthcare Institute LimitedHealthcare4.06%
5Lupin LimitedHealthcare4.04%
6Cipla LimitedHealthcare3.94%
7Aster DM Healthcare LimitedHealthcare3.84%
8Neuland Laboratories LimitedHealthcare3.7%
9Anthem Biosciences LimitedHealthcare3.48%
10Acutaas Chemicals LimitedHealthcare3.24%
11IPCA Laboratories LimitedHealthcare3.23%
12Shilpa Medicare LimitedHealthcare3.1%
13Alkem Laboratories LimitedHealthcare3.06%
14Global Health LimitedHealthcare2.85%
15Rubicon Research LimitedHealthcare2.82%
16Fortis Healthcare LimitedHealthcare2.37%
17Glenmark Pharmaceuticals LimitedHealthcare2.34%
18Krishna Institute of Medical Sciences LimitedHealthcare2.25%
19Vijaya Diagnostic Centre LimitedHealthcare2.24%
20JUPITER LIFE LINE HOSPITALSHealthcare1.94%
21Zydus Lifesciences LimitedHealthcare1.93%
22Dr. Reddy's Laboratories LimitedHealthcare1.9%
23Metropolis Healthcare LimitedHealthcare1.9%
24TREPS - Tri-party Repotreps—1.83%
25MOLBIO DIAGNOSTICS LTDHealthcare1.77%
26Biocon LimitedHealthcare1.73%
27Wockhardt LimitedHealthcare1.61%
28Sai Life Sciences LimitedHealthcare1.6%
29Apollo Hospitals Enterprise LimitedHealthcare1.39%
30Thyrocare Technologies LimitedHealthcare1.31%
31SYMBIOTEC PHARMALAB LTDHealthcare1.21%
32Ajanta Pharma LimitedHealthcare1.18%
33Gland Pharma LimitedHealthcare1.09%
34CORONA Remedies LimitedHealthcare1.07%
35Eris Lifesciences LimitedHealthcare1.06%
36Jubilant Pharmova LimitedHealthcare0.85%
37Bajaj Healthcare LimitedHealthcare0.57%
38Novartis India LimitedHealthcare0.47%
39Laxmi Dental LimitedHealthcare0.38%
40Cohance Lifesciences LimitedHealthcare0.34%
41Net Current Assetsother—-0.25%

More funds from HDFC Mutual Fund

All HDFC Mutual Fund schemes →

Frequently Asked Questions

Yes. As of its 31 August 2026 disclosure, Divi's Laboratories Limited is 9.54% of HDFC Pharma and Healthcare Fund's net assets — its number 1 holding.
Yes. As of its 31 August 2026 disclosure, Sun Pharmaceutical Industries Limited is 8.94% of HDFC Pharma and Healthcare Fund's net assets — its number 2 holding.
Yes. As of its 31 August 2026 disclosure, Torrent Pharmaceuticals Limited is 4.08% of HDFC Pharma and Healthcare Fund's net assets — its number 3 holding.
Yes. As of its 31 August 2026 disclosure, Max Healthcare Institute Limited is 4.06% of HDFC Pharma and Healthcare Fund's net assets — its number 4 holding.
Yes. As of its 31 August 2026 disclosure, Lupin Limited is 4.04% of HDFC Pharma and Healthcare Fund's net assets — its number 5 holding.

New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.

Source: HDFC Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 31 August 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.